1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019) Authors: Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diabetic nephropathy: newer therapeutic perspectives. Issue 4 (4th July 2018) Authors: Keri, Krishna C.; Samji, Naga S.; Blumenthal, Samuel Journal: Journal of community hospital internal medicine perspectives Issue: Volume 8:Issue 4(2018) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary membranous nephropathy: comprehensive review and historical perspective. Issue 1119 (25th January 2019) Authors: Keri, Krishna C; Blumenthal, Samuel; Kulkarni, Varsha; Beck, Laurence; Chongkrairatanakul, Tepsiri Journal: Postgraduate medical journal Issue: Volume 95:Issue 1119(2019) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗